OMV-based vaccine formulations against Shiga toxin producing Escherichia coli strains are both protective in mice and immunogenic in calves

dc.creatorFingermann, Matías
dc.creatorÁvila, Lucía
dc.creatorDe Marco, María
dc.creatorVázquez, Luciana
dc.creatorDi Biase, Darío Nicolás
dc.creatorMüller, Andrea Verónica
dc.creatorLescano, Mirta
dc.creatorDokmetjian, Christian
dc.creatorFernández Castillo, Sonsire
dc.creatorPérez Quiñoy, José Luis
dc.date2021-01-26T15:43:48Z
dc.date2021-01-26T15:43:48Z
dc.date2018-07-12
dc.date.accessioned2023-08-29T20:09:10Z
dc.date.available2023-08-29T20:09:10Z
dc.identifier2164-554X
dc.identifierhttp://sgc.anlis.gob.ar/handle/123456789/2256
dc.identifier10.1080/21645515.2018.1490381
dc.identifier.urihttps://repositorioslatinoamericanos.uchile.cl/handle/2250/8520543
dc.descriptionFil: Fingermann, Matias. ANLIS Dr.C.G.Malbrán. Instituto Nacional de Producción de Biológicos; Argentina.
dc.descriptionFil: Avila, Lucía. ANLIS Dr.C.G.Malbrán. Instituto Nacional de Producción de Biológicos; Argentina.
dc.descriptionFil: De Marco, Maria Belén. ANLIS Dr.C.G.Malbrán. Instituto Nacional de Producción de Biológicos; Argentina.
dc.descriptionFil: Vázquez, Luciana. ANLIS Dr.C.G.Malbrán. Unidad Operativa Centro de Contención Biológica; Argentina.
dc.descriptionFil: Di Biase, Darío Nicolás. ANLIS Dr.C.G.Malbrán. Instituto Nacional de Producción de Biológicos; Argentina.
dc.descriptionFil: Müller, Andrea Verónica. ANLIS Dr.C.G.Malbrán. Instituto Nacional de Producción de Biológicos; Argentina.
dc.descriptionFil: Lescano, Mirta. ANLIS Dr.C.G.Malbrán. Instituto Nacional de Producción de Biológicos; Argentina.
dc.descriptionFil: Dokmetjian, José Christian. ANLIS Dr.C.G.Malbrán. Instituto Nacional de Producción de Biológicos; Argentina.
dc.descriptionFil: Fernández Castillo, Sonsire. Instituto Finlay, La Habana; Cuba.
dc.descriptionFil: Pérez Quiñoy, José Luis. Instituto Finlay, La Habana; Cuba.
dc.descriptionStrains of Shiga toxin-producing Escherichia coli (STEC) can cause the severe Hemolytic Uremic Syndrome (HUS). Shiga toxins are protein toxins that bind and kill microvascular cells, damaging vital organs. No specific therapeutics or vaccines have been licensed for use in humans yet. The most common route of infection is by consumption of dairy or farm products contaminated with STEC. Domestic cattle colonized by STEC strains represent the main reservoir, and thus a source of contamination. Outer Membrane Vesicles (OMV) obtained after detergent treatment of gram-negative bacteria have been used over the past decades for producing many licensed vaccines. These nanoparticles are not only multi-antigenic in nature but also potent immunopotentiators and immunomodulators. Formulations based on chemical-inactivated OMV (OMVi) obtained from a virulent STEC strain (O157:H7 serotype) were found to protect against pathogenicity in a murine model and to be immunogenic in calves. These initial studies suggest that STEC-derived OMV has a potential for the formulation of both human and veterinary vaccines.
dc.formatpdf
dc.languageen
dc.relationHuman Vaccines & Immunotherapeutics
dc.rightsopen
dc.sourceHuman Vaccines & Immunotherapeutics 2018;14(9):2208-2213
dc.subjectBovinos
dc.subjectSíndrome Hemolítico-Urémico
dc.subjectToxina Shiga
dc.subjectVaccinia
dc.subjectZoonosis
dc.titleOMV-based vaccine formulations against Shiga toxin producing Escherichia coli strains are both protective in mice and immunogenic in calves
dc.typeArtículo


Este ítem pertenece a la siguiente institución